Clinical trial
n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy
NCT05145452 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy
- Lead sponsor
- University of Missouri-Columbia
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 14, 2021
- Completion date
- June 26, 2023
- Enrollment
- 31 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.